S. 2761 119th Congress
RESULTS Act
Latest action, Sep 10, 2025: Read twice and referred to the Committee on Finance.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
13 cosponsors
Sponsored by Thom Tillis (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
6 D · 7 R
- Democrat
- Republican
- Independent
Referred to: Senate: Finance Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
5 reports
AMERICAN ASSOCIATION OF BIOANALYSTS
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
5 reports
AMERICAN SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS
WHEAT SHROYER GOVERNMENT RELATIONS LLC
5 reports
ARUP LABORATORIES, INC.
VAN SCOYOC ASSOCIATES
5 reports
BIOMERIEUX, INC.
ALSTON & BIRD LLP
5 reports
5 reports
DH DIAGNOSTICS LLC
TIBER CREEK GROUP
5 reports
5 reports
LABORATORY CORPORATION OF AMERICA HOLDINGS
KELLEY DRYE & WARREN LLP
5 reports
5 reports
QUEST DIAGNOSTICS INCORPORATED
FEDERAL STREET STRATEGIES, LLC
5 reports
5 reports
5 reports
All 25 of 41 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| ADVANCED MEDICAL TECHNOLOGY ASSN | 5 | $5.0M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN ASSOCIATION OF BIOANALYSTS | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 5 | $350K | Q4 2025 | Q3 2026 | yes |
| AMERICAN SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS | WHEAT SHROYER GOVERNMENT RELATIONS LLC | 5 | $100K | Q4 2025 | Q3 2026 | yes |
| ARUP LABORATORIES, INC. | VAN SCOYOC ASSOCIATES | 5 | $150K | Q4 2025 | Q3 2026 | yes |
| BIOMERIEUX, INC. | ALSTON & BIRD LLP | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| COLLEGE OF AMERICAN PATHOLOGISTS | 5 | $968K | Q4 2025 | Q3 2026 | yes | |
| DH DIAGNOSTICS LLC | TIBER CREEK GROUP | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| DH DIAGNOSTICS, LLC | 5 | $1.3M | Q4 2025 | Q3 2026 | yes | |
| F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES | 5 | $520K | Q4 2025 | Q3 2026 | yes | |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | KELLEY DRYE & WARREN LLP | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | 5 | $2.0M | Q4 2025 | Q3 2026 | yes | |
| QUEST DIAGNOSTICS INCORPORATED | 5 | $2.1M | Q4 2025 | Q3 2026 | yes | |
| QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | 5 | $0 | Q4 2025 | Q3 2026 | yes |
| SIEMENS MEDICAL SOLUTIONS USA, INC | 5 | $3.3M | Q4 2025 | Q3 2026 | yes | |
| THERMO FISHER SCIENTIFIC INC | 5 | $2.4M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC | 4 | $7.7M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN CLINICAL LABORATORY ASSN | 4 | $3.3M | Q4 2025 | Q3 2026 | yes | |
| AMERICAN HOSPITAL ASSOCIATION | 4 | $21.0M | Q4 2025 | Q3 2026 | yes | |
| ASSOCIATION FOR MOLECULAR PATHOLOGY | IPOLICY SOLUTIONS | 4 | $282K | Q4 2025 | Q3 2026 | yes |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 4 | $2.5M | Q4 2025 | Q3 2026 | yes | |
| HEALTHCARE INSTITUTE OF NEW JERSEY | 4 | $187K | Q4 2025 | Q3 2026 | yes | |
| MAYO COLLABORATIVE SERVICES, INC. | RAMPY STRATEGIES, LLC | 4 | $240K | Q4 2025 | Q3 2026 | yes |
| QUEST DIAGNOSTICS INCORPORATED | RED+BLUE STRATEGIES | 4 | $0 | Q4 2025 | Q3 2026 | yes |
| SIEMENS HEALTHINEERS | TIBER CREEK GROUP | 4 | $240K | Q4 2025 | Q3 2026 | yes |
| SUTTER HEALTH | VENABLE LLP | 4 | $320K | Q4 2025 | Q3 2026 | yes |